Drug Name: | Triflupromazine (146-54-3) |
---|---|
PubChem ID: | 5568 |
SMILES: | CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F |
InchiKey: | XSCGXQMFQXDFCW-UHFFFAOYSA-N |
Therapeutic Category: | Antiemetics, Antipsychotic Agents, Autonomic Agents, Central Nervous System Agents, Central Nervous System Depressants, Dopamine Agents, Dopamine Antagonists, Gastrointestinal Agents, Neurotransmitter Agents, Peripheral Nervous System Agents, Psychotropic Drugs, Tranquilizing Agents |
Molecular Weight (dalton) | : | 352.425 |
LogP | : | 5.2598 |
Ring Count | : | 2 |
Hydrogen Bond Acceptor Count | : | 3 |
Hydrogen Bond Donor Count | : | 0 |
Total Polar Surface Area | : | 6.48 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category
Toxicity | Source |
---|---|
Akathisia Drug-Induced | MetaADEDB |
Basal Ganglia Diseases | MetaADEDB |
Hyperemesis Gravidarum | MetaADEDB |